Maze Therapeutics, a kidney disease therapy developer, recently IPO-ed with a market cap of $487mn and significant early-stage investor backing. Lead asset MZE829 targets APOL1 Kidney Disease, showing ...

Relay Therapeutics has a promising 4D drug design platform but faces challenges with limited clinical data and high R&D expenses. Despite a strong IPO and substantial cash reserves, the stock has ...

Look almost anywhere in your home and you’ll likely find something made of silicone. Unfortunately, manufacturing silicone-based materials comes with a high environmental cost that is largely due to ...

Natural history. Physics. Astronomy. Medicine. Math. Engineering. Climate science. Over its 50-year history, NOVA has presented discoveries and mind-blowing science phenomena in each of these ...